- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03930966
Association Between a Peri-traumatic Dissociation State and the Occurrence of Post-traumatic Stress Syndrome (DIStress-AG)
Study of the Association Between a Peri-traumatic Dissociation State and the Occurrence of Post-traumatic Stress Syndrome After Severe Trauma Requiring General Anesthesia
Patients will be selected after studying clinical records.Patients who had general anesthesia due to an injury related to severe trauma within 6 to 12 months prior to inclusion will be included.
Three self-survey will be completed by the patient: PDEQ, PCL-5 and a demographic questionnaire. According to the PDEQ and PCL-5 scores, an association between a peri-traumatic dissociation state and a post-traumatic stress disorder can be established.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Brest, France, 29200
- CHRU Brest
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with general anesthesia for a surgical wound with violent trauma in the road, a fall of more than 6 meters, burn, accident at work, explosion, aggression) in the 6 to 12 months before the inclusion
- Time between trauma and general anesthesia should not exceed 48 hours
- Patient agreeing to participate in the study.
Exclusion Criteria:
- Minor patients
- Patients under curatorship, and tutorship
- Patient deprived of liberty
- Patients who do not speak French
- Patients who are not in satisfactory neurological state to answer the questionnaire (pyschotic, demented states)
- Patients who have been sedated (apart from general anesthesia) when receiving or having a Glasgow score <14
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PDEQ, PCL-5 and demographic survey
State of the patient evaluated with questionnaires to make the connection between peri-traumatic dissociation and the occurrence of post-traumatic stress disorder
|
Questionnaires
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Studying association between the presence of peri-traumatic dissociation state and the achievement of post-traumatic stress disorder between 6 and 12 months in traumatized patients
Time Frame: study baseline (6 to 12 months after initial hospitalisation)
|
Association will be measured using PDEQ scale and PCL-5 scale. The peri-traumatic dissociation will be evaluated by the Peri-traumatique Dissociation Experience Questionnary (PDEQ scale). This questionnaire contains ten items to study the presence or not of a peri-traumatic dissociation state. The items are scored on a 5-point Likert scale ranging from 1 (not at all true) to 5 (extremely true). The total score is the sum of all the items. A score from 15 indicates a significant dissociation. The presence or not of a Post-Traumatic Stress Disorder (PTSD) will be evaluated by the Post-Traumatic Stress Disorder Checklist Scale-Version DSM 5 (PCL-5). This questionnaire contains twenty items to study the presence or not of a PTSD. A total score for symptom severity (0-80) can be obtained by summing the scores for each of the 20 items. A score over 31 indicates a PTSD. |
study baseline (6 to 12 months after initial hospitalisation)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Measurement of the frequency of PTSD after severe trauma requiring general anesthesia.
Time Frame: study baseline (6 to 12 months after initial hospitalisation)
|
study baseline (6 to 12 months after initial hospitalisation)
|
Research of Risk Factors Associated with the Occurrence of PTSD
Time Frame: study baseline (6 to 12 months after initial hospitalisation)
|
study baseline (6 to 12 months after initial hospitalisation)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Philippe ARIES, Dr, philippe.aries@chu-brest.fr
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DIStress-AG (29BRC18.0200)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Study Protocol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on General Anaesthesia
-
B. Braun Melsungen AGTigermed Consulting Co., Ltd; B. Braun Medical International Trading Company...CompletedGeneral Anaesthesia | Induction of AnaesthesiaChina
-
Centre Hospitalier Universitaire DijonCompletedOpioid Free Anaesthesia | Opioid AnaesthesiaFrance
-
Centre Hospitalier Universitaire DijonCompletedOpioid Free Anaesthesia | Opioid AnaesthesiaFrance
-
Algemeen Stedelijk ZiekenhuisNot yet recruitingPostoperative Opioid-Sparing Effect of a Pecto-Intercostal Fascial Block and Opioid-Free Anesthesia.Opioid Free Anaesthesia | Opioid Anaesthesia
-
Jan JakobssonUniversity of California, IrvineTerminated
-
Zhang HaopengCompleted
-
University Hospital Schleswig-HolsteinCompleted
-
R-PharmSynergy Research Inc.CompletedGeneral AnaesthesiaRussian Federation
-
Universiti Sains MalaysiaAmbu A/SCompletedGeneral AnaesthesiaMalaysia
-
Oslo University HospitalThe Research Council of Norway; Danmeter (Denmark)Unknown
Clinical Trials on PDEQ, PCL-5 and demographic survey
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedCervical CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedObesity | Healthy, no Evidence of Disease | Weight ChangesUnited States
-
King's College Hospital NHS TrustCompletedLung Cancer | Metastatic Cancer | DyspneaUnited Kingdom
-
Centre for Evidence-Based Practice, BelgiumGilead Sciences; University Hospital, Ghent; Institute of Tropical Medicine,... and other collaboratorsCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedColorectal CancerUnited States
-
Hospital Sao DomingosNot yet recruitingCOVID-19 Post-Intensive Care Syndrome
-
University of Colorado, DenverNational Cancer Institute (NCI)CompletedDepression | Breast Cancer | Prostate Cancer | Psychosocial Effects of Cancer and Its Treatment | Long-term Effects of Cancer TreatmentUnited States
-
Case Comprehensive Cancer CenterTerminatedBreast Cancer | Colorectal Cancer | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
China Medical University HospitalCompletedChronic Rhinosinusitis
-
Tel-Aviv Sourasky Medical CenterCompleted